The abstract is read at the publisher; the summary is JClub's.
ssDNA gaps are elevated during replication in BRCA-deficient models, and higher gap burden is linked to PARP inhibitor sensitivity, including in BRCA-deficient xenografts.
- Why it matters: Existing HRD biomarkers focus on double-strand breaks, leaving replication-associated ssDNA gaps undetected in clinical workflows despite their reported therapeutic relevance.
- What they did: The team built a scalable, drug-free assay for real-time ssDNA gap detection, showing gaps depend on PRIMPOL-dependent repriming and nuclease processing, then used AI image analysis to quantify gaps in xenograft specimens.
- The result: Across diverse cell line models, PARPi sensitivity is associated with gap burden regardless of BRCA status, and in BRCA-deficient xenografts elevated gaps track PARPi sensitivity, supporting translational biomarker potential.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.